Large-Scale Neo-Cartilage Engineering: regenerative treatment technologies for osteoarthritis (LS-NeoCarE)
More than 1.5 million people in the Netherlands suffer from osteoarthritis – a degenerative joint disease. For many osteoarthritis patients, there is currently no treatment that can slow the disease process or cure it. Therefore, they struggle with pain and movement limitations every day. LS-NeoCarE wants to improve their lives by developing durable regenerative cartilage implants. These living implants are based on revolutionary stem cell, bioreactor, and 3D-printing technologies. Through the active involvement of researchers, industry, doctors, and patient organizations, the project creates support among both patients and doctors for applicability and with industry for marketing the developed implants.
Official secretary on behalf of the consortium: prof. dr. ir. K. (Keita) Ito – Eindhoven University of Technology
Consortium: Eindhoven University of Technology, Leiden University Medical Center, UMC Utrecht, Utrecht University, Leiden University, Fontys University of Applied Sciences, University of Applied Sciences Utrecht, University of Applied Sciences Leiden, Regenerative Medicine Crossing Borders, Purac Biochem BV, Demcon, Scinus Cell Expansion BV, ASR Zorgverzekering, NC Biomatrix BV, Azar Innovations, Poietis France, Dutch Arthritis Foundation (ReumaNederland), patient participation arthritis Leiden LUMC (PPA-Leiden).
Amount awarded: 3.2 million Euros